Related Experiment Video
Updated: Aug 18, 2026

Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach
Published on: June 23, 2026
The development of monocyclic pyrazolone based cytokine synthesis inhibitors
Adam Golebiowski1, Jennifer A Townes, Matthew J Laufersweiler
1Procter and Gamble Pharmaceuticals, Health Care Research Center, 8700 Mason-Montgomery Rd, Mason, OH 45040, USA. golebiowski.a@pg.com
Abstract:
4-Aryl-5-pyrimidyl based cytokine synthesis inhibitors that contain a novel monocyclic, pyrazolone heterocyclic core are described. Many of these inhibitors showed low nanomolar activity against LPS-induced TNF-alpha production. One of the compounds (6e) was found to be efficacious in the rat iodoacetate (RIA) in vivo model of osteoarthritis. The X-ray crystal structure of a pyrazolone inhibitor cocrystallized with mutated p38 (mp38) is presented.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Antiviral Nucleoside Inhibitors
The JAK-STAT Signaling Pathway
Inhibition of Cdk Activity
Inhibitors of Virion Maturation and Assembly
Inhibitors of Bacterial DNA Synthesis
